Clinical Trial Update: Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pentostatin, cyclophosphamide, and rituximab in patients with previously untreated chronic lymphocytic leukemia. The results report on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Cytoxan (cyclophosphamide)
• NIPENT (pentostatin)
• Rituxan (rituximab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2017-02-27